Mounjaro (tirzepatide) is a prescription drug used to help manage blood sugar levels in adults with type 2 diabetes. Mounjaro comes as an injection that’s given under your skin. This medication ...

Mounjaro can cause side effects that range from mild to serious. The most common side effects include nausea, diarrhea, and decreased appetite. Mounjaro (tirzepatide) is prescribed to help manage ...

Shares of Eli Lilly & Co. were headed for their worst day in nearly four years on Tuesday after the drugmaker provided a fourth-quarter revenue outlook that was below expectations, citing slower ...

LIV Golf has named Scott O’Neil as its new CEO, replacing Greg Norman, who has held the position for the Saudi-backed league since its inception in 2021. O’Neil will drive the strategic vision ...

The latest to join the ranks is the so-called “natural Mounjaro” drink for weight loss. Recipes vary slightly depending on which one you find, but the natural Mounjaro drink generally consists of ...

Copyright 2025 The Associated Press. All Rights Reserved. Philadelphia 76ers chief executive officer Scott O’Neil speaks to reporters at the team’s NBA basketball ...

A long-anticipated signing has now been made official. The LIV Golf League announced Scott O'Neil as its new Chief Executive Officer on Wednesday, replacing Greg Norman, who will remain involved with ...

Greg Norman officially is out as LIV Golf CEO. The Saudi Arabia-backed league announced on Wednesday that Scott O'Neil, a longtime sports and entertainment executive, is taking over immediately as ...

The company attributed the revision to lower-than-expected sales of tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for obesity. “It’s always disappointing to miss your own ...

Mounjaro (tirzepatide) is a brand-name drug prescribed to treat type 2 diabetes in adults. Mounjaro comes as a solution inside injection pens that you’ll administer weekly as a subcutaneous ...

Incretins such as glucagon-like peptide-1, or GLP-1, are used in diabetes and obesity drugs like Eli Lilly's Mounjaro and Zepbound. The stock (LLY) dropped 8.2% in morning trading, enough to make ...